UHPLC-MS/MS -based Untargeted Lipidomics Analysis of Septic Patients.

[1]  Henry E. Wang,et al.  Sepsis is a preventable public health problem , 2018, Critical Care.

[2]  J. Medin,et al.  Sphingolipid pathway enzymes modulate cell fate and immune responses. , 2017, Immunotherapy.

[3]  A. Bai,et al.  Acid sphingomyelinase mediates human CD4+ T-cell signaling: potential roles in T-cell responses and diseases , 2017, Cell Death and Disease.

[4]  L. Fantuzzi,et al.  Macrophages and Phospholipases at the Intersection between Inflammation and the Pathogenesis of HIV-1 Infection , 2017, International journal of molecular sciences.

[5]  Niranjan Kissoon,et al.  Recognizing Sepsis as a Global Health Priority - A WHO Resolution. , 2017, The New England journal of medicine.

[6]  Arkasubhra Ghosh,et al.  Biofluid lipidome: a source for potential diagnostic biomarkers , 2017, Clinical and Translational Medicine.

[7]  M. Levy,et al.  Management of Septic Shock. , 2017, The New England journal of medicine.

[8]  M. Howell,et al.  Management of Sepsis and Septic Shock. , 2017, JAMA.

[9]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[10]  D. Angus,et al.  Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. , 2016, American journal of respiratory and critical care medicine.

[11]  C. D. dos Santos.  Shedding metabo‘light’ on the search for sepsis biomarkers , 2015, Critical Care.

[12]  G. Kroemer,et al.  Phosphatidylethanolamine positively regulates autophagy and longevity , 2015, Cell Death and Differentiation.

[13]  Sang-Bum Hong,et al.  Impact of serial measurements of lysophosphatidylcholine on 28-day mortality prediction in patients admitted to the intensive care unit with severe sepsis or septic shock. , 2014, Journal of critical care.

[14]  T. Okazaki,et al.  The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders. , 2014, Biochimica et biophysica acta.

[15]  S. Caspar-Bauguil,et al.  Alteration of plasma phospholipid fatty acid profile in patients with septic shock. , 2013, Biochimie.

[16]  J. W. Brewer,et al.  Phospholipids: "greasing the wheels" of humoral immunity. , 2013, Biochimica et biophysica acta.

[17]  C. Fauriat,et al.  Molecular Mechanisms of Natural Killer Cell Activation , 2011, Journal of Innate Immunity.

[18]  Xianlin Han,et al.  Lipidomics at the interface of structure and function in systems biology. , 2011, Chemistry & biology.

[19]  Eoin Fahy,et al.  Lipidomics reveals a remarkable diversity of lipids in human plasma1[S] , 2010, Journal of Lipid Research.

[20]  Xin-ru Liu,et al.  A metabonomic approach to early prognostic evaluation of experimental sepsis. , 2008, The Journal of infection.

[21]  J. Cronan.  Phospholipid modifications in bacteria. , 2002, Current opinion in microbiology.

[22]  V. Aidinis,et al.  Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes. , 2013, Biochimica et biophysica acta.

[23]  M. Lagarde,et al.  Membranes and bioactive lipids. , 2013, Biochimie.